Latest Regulatory Challenges News

Advance Zintek reports a robust 26.83% revenue increase in Q1 FY26, driven by strong growth across North America, Australia, and Europe, despite regulatory hurdles impacting zinc oxide sales in Australia.

La Trobe Financial confirms the resolution of regulatory issues as ASIC lifts the Interim Stop Order on its 12 Month Term Account, restoring investor confidence.

The NSW Independent Casino Commission has prolonged the suspension of The Star Sydney casino licence and extended the manager’s term, signaling ongoing regulatory scrutiny and remediation efforts.

An application to the Takeovers Panel challenges Duxton Farms’ recent merger and share placement, alleging undisclosed associations and potential breaches of takeover laws by major shareholders.

Peak Rare Earths Limited shareholders are set to vote on Shenghe Resources’ $195 million acquisition offer, which includes a 32% premium over recent share prices. Despite a higher unsolicited bid from GICP, the board recommends accepting Shenghe’s proposal.

The Takeovers Panel has declined to conduct proceedings regarding Elanor Funds Management's concerns over disclosure in the LDR Assets takeover bid, as parties move to amend the bidder's statement.

Duxton Farms proposes to acquire all preference shares of Duxton Bees via a scheme of arrangement, offering 0.839 Duxton Farms shares per Duxton Bees preference share, with up to 20% cash consideration. The independent expert values Duxton Bees preference shares between $0.64 and $0.85 on a control basis and considers the transaction fair and reasonable.

Elanor Funds Management has lodged an application with the Takeovers Panel contesting disclosure deficiencies in Lederer’s takeover bid for Elanor Commercial Property Fund. The dispute centers on transparency around ownership, management, and strategic intentions.

IMEXHS Limited reported steady revenue growth and a strategic push to scale its SaaS medical imaging platform, while navigating margin challenges and regulatory risks in Colombia.

MedAdvisor reported a 36% revenue drop in FY25, driven by US health program setbacks, and sold its ANZ business to focus on restructuring its US operations.

Careteq Limited has returned to profitability in FY25, reporting a 5.4% revenue increase and a 171% jump in underlying EBITDA, driven by strategic divestments and acquisitions.

Careteq Limited reported a dramatic reduction in its FY25 loss to just $72,204, down from $2.67 million the prior year, while facing a significant $3.6 million dispute with the Australian Taxation Office over R&D tax claims.